These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 16959589)
81. Hyperandrogenism, insulin resistance and hyperinsulinemia as cardiovascular risk factors in diabetes mellitus. García-Romero G; Escobar-Morreale HF Curr Diabetes Rev; 2006 Feb; 2(1):39-49. PubMed ID: 18220616 [TBL] [Abstract][Full Text] [Related]
82. [Hyperinsulinism as a major etiopathogenic link with arterial hypertension, hyperlipoproteinemia and hirsutism. II]. Hrnciar J; Hrnciarová M; Jakubíková K; Okapcová J Vnitr Lek; 1992 May; 38(5):438-47. PubMed ID: 1509713 [TBL] [Abstract][Full Text] [Related]
85. [Obesity--significance in adolescence and for reproduction]. Wolf AS; Sterzik K Zentralbl Gynakol; 1998; 120(5):210-22. PubMed ID: 9629628 [TBL] [Abstract][Full Text] [Related]
86. [Risk factors for atherosclerosis in non-insulin-dependent diabetes]. Van Gaal LF; de Leeuw IH Journ Annu Diabetol Hotel Dieu; 1992; ():101-12. PubMed ID: 1495229 [No Abstract] [Full Text] [Related]
87. The importance of diagnosing the polycystic ovary syndrome. Lobo RA; Carmina E Ann Intern Med; 2000 Jun; 132(12):989-93. PubMed ID: 10858183 [TBL] [Abstract][Full Text] [Related]
88. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Brzozowska MM; Ostapowicz G; Weltman MD J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335 [TBL] [Abstract][Full Text] [Related]
89. Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection. Lunde O; Tanbo T Gynecol Endocrinol; 2007 Dec; 23(12):704-9. PubMed ID: 18075845 [TBL] [Abstract][Full Text] [Related]
91. Metabolic alterations and cardiovascular risk factors in the polycystic ovary syndrome. Pasquali R; Patton L; Pagotto U; Gambineri A Minerva Ginecol; 2005 Feb; 57(1):79-85. PubMed ID: 15758867 [TBL] [Abstract][Full Text] [Related]
92. Polycystic ovary syndrome: a risk for coronary artery disease? Wild RA Am J Obstet Gynecol; 2002 Jan; 186(1):35-43. PubMed ID: 11810081 [TBL] [Abstract][Full Text] [Related]
93. Early diagnosis, presenting complaints, and management of hyperandrogenism in adolescents. Schroeder B Curr Womens Health Rep; 2001 Oct; 1(2):124-30. PubMed ID: 12112959 [TBL] [Abstract][Full Text] [Related]
94. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome. Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421 [TBL] [Abstract][Full Text] [Related]
95. Preventing heart failure in patients with diabetes. Srikanthan P; Hsueh W Med Clin North Am; 2004 Sep; 88(5):1237-56. PubMed ID: 15331315 [TBL] [Abstract][Full Text] [Related]
96. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559 [TBL] [Abstract][Full Text] [Related]
97. [The role of leptin in polycystic ovary syndrome]. Marciniak A; Starczewski A Pol Merkur Lekarski; 2008 Oct; 25(148):390-3. PubMed ID: 19145943 [TBL] [Abstract][Full Text] [Related]
98. [Current criterion for diagnosing polycystic ovary syndrome]. Zárate A; Morán C; Hernández M; Saucedo R Ginecol Obstet Mex; 2004 Jun; 72():283-6. PubMed ID: 15462547 [TBL] [Abstract][Full Text] [Related]